Saecker Luisa, Häberlein Hanns, Franken Sebastian
Institute of Biochemistry and Molecular Biology, Medical Faculty, University of Bonn, Bonn, Germany.
Front Pharmacol. 2023 May 30;14:1172551. doi: 10.3389/fphar.2023.1172551. eCollection 2023.
Adenosine A1 receptor (AAR) plays a prominent role in neurological and cardiac diseases and inflammatory processes. Its endogenous ligand adenosine is known to be one of the key players in the sleep-wake cycle. Like other G protein-coupled receptors (GPCRs), stimulation of AAR leads to the recruitment of arrestins in addition to the activation of G proteins. So far, little is known about the role of these proteins in signal transduction and regulation of AAR compared to the activation of G proteins. In this work, we characterized a live cell assay for AAR-mediated β-arrestin 2 recruitment. We have applied this assay to a set of different compounds that interact with this receptor. Based on NanoBit technology, a protein complementation assay was developed in which the AAR is coupled to the large part of the nanoluciferase (LgBiT), whereas its small part (SmBiT) is fused to the N-terminus of β-arrestin 2. Stimulation of AAR results in the recruitment of β-arrestin 2 and subsequent complementation of a functional nanoluciferase. For comparison, corresponding data on the effect of receptor stimulation on intracellular cAMP levels were collected for some data sets using the GloSensor™ assay. The assay gives highly reproducible results with a very good signal-to-noise ratio. Capadenoson, in contrast to adenosine, CPA, or NECA, shows only partial agonism in this assay with respect to the recruitment of β-arrestin 2, whereas it shows full agonism in the case of the inhibitory effect of AAR on cAMP production. By using a GRK2 inhibitor, it becomes clear that the recruitment is at least partially dependent on the phosphorylation of the receptor by this kinase. Interestingly, this was also the first time that we demonstrate the AAR-mediated recruitment of β-arrestin 2 by stimulation with a valerian extract. The presented assay is a useful tool for the quantitative study of AAR-mediated β-arrestin 2 recruitment. It allows data collection for stimulatory, inhibitory, and modulatory substances and is also suitable for more complex substance mixtures such as valerian extract.
腺苷A1受体(AAR)在神经疾病、心脏疾病和炎症过程中发挥着重要作用。已知其内源配体腺苷是睡眠-觉醒周期的关键参与者之一。与其他G蛋白偶联受体(GPCR)一样,AAR的刺激除了激活G蛋白外,还会导致抑制蛋白的募集。到目前为止,与G蛋白的激活相比,这些蛋白在AAR信号转导和调节中的作用知之甚少。在这项工作中,我们对AAR介导的β-抑制蛋白2募集的活细胞分析方法进行了表征。我们将此分析方法应用于一组与该受体相互作用的不同化合物。基于NanoBit技术,开发了一种蛋白质互补分析方法,其中AAR与纳米荧光素酶(LgBiT)的大部分偶联,而其小部分(SmBiT)与β-抑制蛋白2的N端融合。AAR的刺激导致β-抑制蛋白2的募集以及功能性纳米荧光素酶的后续互补。为了进行比较,使用GloSensor™分析方法为一些数据集收集了受体刺激对细胞内cAMP水平影响的相应数据。该分析方法给出了具有非常好的信噪比的高度可重复结果。与腺苷、CPA或NECA相比,卡帕地尔在该分析中就β-抑制蛋白2的募集而言仅表现出部分激动作用,而在AAR对cAMP产生的抑制作用方面则表现出完全激动作用。通过使用GRK2抑制剂,很明显募集至少部分依赖于该激酶对受体的磷酸化作用。有趣的是,这也是我们首次证明用缬草提取物刺激可介导AAR对β-抑制蛋白2的募集。所展示的分析方法是定量研究AAR介导的β-抑制蛋白2募集的有用工具。它允许收集刺激、抑制和调节物质的数据,也适用于更复杂的物质混合物,如缬草提取物。